Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer
Le‐Tian Huang, Shuling Zhang, Cheng‐Bo Han, Jie‐Tao Ma
Topics & Concepts
MedicineT790MInternal medicineEpidermal growth factor receptorHazard ratioOncologyLung cancerRetrospective cohort studyProgression-free survivalCancerGefitinibConfidence intervalOverall survivalLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers